Oncogene - Nature
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.

Browse Articles | Oncogene - Nature
Browse the archive of articles on Oncogene Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop Begoña Caballero ...

Research articles | Oncogene - Nature
Read the latest Research articles from Oncogene Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop Begoña ...

Oncogenes - Latest research and news | Nature
Together, these findings identify a unifying mechanism that links transcription factor activity, chromatin topology and oncogene control.

Journal Information | Oncogene - Nature
Areas covered by Oncogene include, but are not limited to, the cellular and molecular biology of cancer including resistance to cancer therapies, and development of better approaches to improving ...

Volume 44 | Oncogene - Nature
Browse all the issues in Volume 44 of Oncogene

Necrosis as a fundamental driver of loss of resilience and ... - Nature
Joseph V. Bonventre, Alexander W. Justin, Kianoush Kashani, Elizabeth Reynolds, Keith Siew, Bill Davis, Halime Karakoy, Nikodem Grzesiak & Damian Miles Bailey Oncogene 44, 1893–1904 (2025) Cite ...

Volume 43 | Oncogene - Nature
Explore Volume 43 of Oncogene journal featuring research articles, reviews, and studies on cancer biology and related fields.

Comprehensive single-cell analysis reveals mast cells’ roles in cancer ...
Wenbo Wang, Jiaomeng Pan, Ming Zhao, Li Gao, Jia Zeng, Hang Gong, Guangyan Zhangyuan, Zi Li, Mao Zhang, Xia Shen, Yuanchi Weng, Xiaxing Deng & Yingying Huang Oncogene 44, 4427–4439 (2025) Cite ...

EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by ...
EZH2 has been shown as a major oncogene and a therapeutic target in various cancers for over two decades, and numerous EZH2 inhibitors have been developed and tested in preclinical models and ...